$0.1192
-0.026-17.91%
Last update: Nov 9, 10:41 AM
Silexion Therapeutics Corp (SLXN) Stock Price, Quote, News & History
SLXNNASDAQ
Silexion Therapeutics shares jump after hours on positive SIL204 preclinical findings for KRAS-driven cancers.
You can purchase shares of Silexion Therapeutics (NASDAQ:SLXN) through any online brokerage.
Other companies in Silexion Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Silexion Therapeutics has a consensus price target of $405.00.
The stock price for Silexion Therapeutics (NASDAQ: SLXN) is $0.1192 last updated November 9, 2026 at 10:41 AM EST.
There are no upcoming dividends for Silexion Therapeutics.
Silexion Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Silexion Therapeutics.
Silexion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene...
